Organon EVP exercises 14,184 RSUs into stock
Organon & Co. Executive VP, Corp. Dev.
Rhea-AI Filing Summary
Organon & Co. Executive VP, Corp. Dev. Daniel Karp exercised 14,184 Restricted Stock Units into common stock. The RSUs converted one-for-one into Organon shares at a stated price of $0.00 per unit.
To satisfy tax obligations, 4,446 shares of common stock were withheld at a reference price of $5.84 per share, based on the closing market price on March 27, 2026 as required under the plan. Following these transactions, Karp directly holds 57,153.923 shares of Organon common stock, which includes 746.463 shares acquired from dividend equivalents net of withholding tax. The RSUs vest and are distributed in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.
Positive
- None.
Negative
- None.
Insider Trade Summary
14,184 shares exercised/converted
Exercise
3 txns
Insider
Karp Daniel
Role
Executive VP, Corp. Dev.
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 14,184 | $0.00 | $0.00 |
| Exercise | Common Stock | 14,184 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 4,446 | $5.84 | $26K |
Holdings After Transaction:
Restricted Stock Units — 14,185 contracts (Direct);
Common Stock — 57,153.923 shares (Direct)
Footnotes (4)
- F1. This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 27, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded.
- F2. Includes the addition of 746.463 shares of Organon common stock acquired from dividend equivalents net of withholding tax not previously required to be reported.
- F3. Each RSU converts into one share of Organon common stock.
- F4. These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.
Key Figures
RSUs exercised: 14,184 units
Tax-withholding shares: 4,446 shares at $5.84
Post-transaction holdings: 57,153.923 shares
+2 more
5 metrics
RSUs exercised
14,184 units
Restricted Stock Units converted to common stock on March 29, 2026
Tax-withholding shares
4,446 shares at $5.84
Shares delivered to cover tax liability on March 29, 2026
Post-transaction holdings
57,153.923 shares
Common stock directly held by Daniel Karp after transactions
Dividend equivalent shares
746.463 shares
Common stock from dividend equivalents net of withholding tax
RSU vesting schedule
3 equal installments
Vesting on March 29, 2025, 2026, and 2027
Key Terms
Restricted Stock Units, dividend equivalents, tax-withholding disposition, exercise or conversion of derivative security, +1 more
5 terms
Restricted Stock Units financial
"The RSUs converted one-for-one into Organon shares at a stated price"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
dividend equivalents financial
"includes 746.463 shares of Organon common stock acquired from dividend equivalents"
Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.
tax-withholding disposition financial
"transaction_action was a tax-withholding disposition of 4,446 shares"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
exercise or conversion of derivative security financial
"transaction_code_description notes an exercise or conversion of derivative security"
closing market price financial
"price is the closing market price of Organon common stock on March 27, 2026"
FAQ
What insider transaction did Organon (OGN) report for Daniel Karp?
Organon reported that Executive VP, Corp. Dev. Daniel Karp exercised 14,184 Restricted Stock Units into common stock. The transaction reflects routine equity compensation vesting rather than an open-market stock purchase or sale, and is recorded as a derivative exercise on March 29, 2026.
What was the size of the RSU exercise reported for Organon (OGN)?
The filing shows Daniel Karp exercised 14,184 Restricted Stock Units, each converting into one share of Organon common stock. The RSUs carried a stated exercise or conversion price of $0.00 per unit, consistent with equity awards that vest into shares rather than being purchased for cash.
How do Daniel Karp’s Organon (OGN) RSUs vest over time?
The RSUs reported vest and are distributed as Organon common stock in three equal installments. The scheduled vesting dates are March 29, 2025, March 29, 2026, and March 29, 2027, reflecting a multi-year equity compensation structure for the executive.
What does each Organon (OGN) RSU convert into for Daniel Karp?
Each Restricted Stock Unit converts into one share of Organon common stock according to the filing. This one-for-one conversion means the 14,184 RSUs exercised resulted in 14,184 shares before accounting for any shares withheld to cover associated tax liabilities.
AI-generated analysis. How Rhea-AI works. Not financial advice.
